Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for OLN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OLN and 80,000+ other tickers.
See exactly how OLN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OLN and 80,000+ other tickers.
Olin Corporation is a global producer and supplier of chemical products, serving markets across the United States, Europe, and internationally. The company's operations are divided into three distinct business segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment provides a comprehensive range of fundamental industrial chemicals. These include chlorine and caustic soda, key vinyl compounds such as ethylene dichloride and vinyl chloride monomers, and various chlorinated organic compounds like methyl chloride, methylene chloride…
OLN's cost cuts and planned Huntsman merger could boost earnings, while weak demand, leverage and cash flow remain key headwinds.
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Huntsman NYSE: HUN stockholders approved the company's proposed merger agreement with Olin Corporation during a virtual special meeting held in 2026, clearing a key shareholder-vote requirement for the planned business combination.
Olin and Huntsman's shareholders overwhelmingly back their all-stock merger, advancing a $12.5 billion chemicals combination targeting more than $400 million in benefits.
Olin remains a valuable opportunity despite operational setbacks, sector headwinds, and a 12% share price decline over the past year. OLN's Q2 was impacted by a $40M Freeport outage, weak demand, and working capital drag, but its epoxy and ammunition businesses showed resilience. The pending Huntsman merger, expected by mid-2027, should drive $250M in cost synergies and improve OLN's free cash flow and leverage profile.